RIPE-KG · Version 1.1.0 · Resource

ripekg:study-design-evidence/RIPEAEADB33420805D4F9

https://w3id.org/ripe/ripe-kg/study-design-evidence/RIPEAEADB33420805D4F9
SubjectPredicateObject
ripekg:evaluation/RIPEAEADB33420805D4F9 prov:used ripekg:study-design-evidence/RIPEAEADB33420805D4F9
ripekg:study-design-evidence/RIPEAEADB33420805D4F9 rdf:type rdfs:Resource
ripekg:study-design-evidence/RIPEAEADB33420805D4F9 rdf:type owl:Thing
ripekg:study-design-evidence/RIPEAEADB33420805D4F9 rdf:type ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence
ripekg:study-design-evidence/RIPEAEADB33420805D4F9 rdf:type ripe:StudyDesignEvidenceStudy design evidence
ripekg:study-design-evidence/RIPEAEADB33420805D4F9 rdf:type tido:Evidence
ripekg:study-design-evidence/RIPEAEADB33420805D4F9 prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEAEADB33420805D4F9
ripekg:study-design-evidence/RIPEAEADB33420805D4F9 prov:wasMemberOf ripekg:research-integrity-assessment/RIPEAEADB33420805D4F9
ripekg:study-design-evidence/RIPEAEADB33420805D4F9 ripe:concerns ripekg:work/10.1371%2Fjournal.pone.0279347Does receiving a SARS-CoV-2 antibody test result change COVID-19 protective behaviors? Testing risk compensation in undergraduate students with a randomized controlled trial
ripekg:study-design-evidence/RIPEAEADB33420805D4F9 ripe:recruitmentEndDate 30-09-2020
ripekg:study-design-evidence/RIPEAEADB33420805D4F9 ripe:recruitmentEndDateExtractionRationale Methods: 'Participants attended an in-person clinic visit for baseline antibody testing between September 14 and 30, 2020...'; using the later date as the recruitment finish date.
ripekg:study-design-evidence/RIPEAEADB33420805D4F9 ripe:recruitmentStartDate 14-09-2020
ripekg:study-design-evidence/RIPEAEADB33420805D4F9 ripe:recruitmentStartDateExtractionRationale Methods: 'Participants attended an in-person clinic visit for baseline antibody testing between September 14 and 30, 2020...'; using the earlier date as the recruitment start date.
ripekg:study-design-evidence/RIPEAEADB33420805D4F9 ripe:studyEndDate 14-11-2020
ripekg:study-design-evidence/RIPEAEADB33420805D4F9 ripe:studyEndDateExtractionRationale Methods: 'Participants attended an in-person clinic visit for baseline antibody testing between September 14 and 30, 2020, and again for a second antibody test between November 8-14, 2020.'; using the later date as the study end date.
ripekg:study-design-evidence/RIPEAEADB33420805D4F9 tido:supports ripekg:integrity-assessment-hypothesis/RIPEAEADB33420805D4F9-human-2-2
ripekg:study-design-evidence/RIPEAEADB33420805D4F9 tido:supports ripekg:integrity-assessment-hypothesis/RIPEAEADB33420805D4F9-inspectai-2-2